← FDA DRUG APPROVALS

FDA ANDA · ANDA077180

MOMETASONE FUROATE

Sponsor: PADAGIS ISRAEL

APPLICATION
ANDA077180
TYPE
ANDA
ORIGINAL APPROVAL
2005-04-06
LATEST ACTION
2019-10-08
ROUTE
TOPICAL
DOSAGE FORM
LOTION
MARKETING STATUS
Prescription

Products

MOMETASONE FUROATEPrescription
MOMETASONE FUROATE 0.1% · LOTION · TOPICAL

Approval history

2019-10-08Labeling · Supplement 9 · standardAP
2015-07-27Labeling · Supplement 4 · standardAP
2005-04-06OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →